By Diana Novak Jones Feb 13 (Reuters) - A jury in Pennsylvania state court on Friday awarded $250,000 to the family of a ...

Rare but dangerous blood clotting associated with that vaccine as well as AstraZeneca’s had a genetic cause, according to a new paper.

When people get the shots, the body’s immune system can accidentally confuse a normal protein from adenovirus - which is used ...

A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...

A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...

A federal judge ruled that allegations of Johnson & Johnson’s mismanagement of employee health plans’ prescription drug benefits remained too speculative. A federal judge in New Jersey once again ...

Jessica Dean, of Dallas-based Dean Omar Branham Shirley, talked to Law.com about the $1.5 billion talc verdict that jurors in Baltimore, Maryland, returned on Monday against Johnson & Johnson. The ...

Editor’s Note: The story has been updated with comments from J&J The National Institutes of Health (NIH) on Tuesday ...

Johnson & Johnson JNJ on Friday after hours released data from the OMNY-AF pilot study, a prospective, single-arm, multi-center trial. The study pairs the OMNYPULSE Catheter, a 12 mm large-tip focal ...

Johnson & Johnson is taking flight with the New York Jets, joining the NFL team’s roster in a multiyear agreement as its official medical innovation sponsor. Under the new sponsorship, unveiled ...

Our machine-driven multifactor analysis suggests it may be time to sell JNJ stock, as we hold a pessimistic outlook with a potential target price of $134. The company’s Moderate operating performance ...

Breaking up isn’t so hard to do, after all. Just two years after spinning off its consumer products as Kenvue Inc., Johnson & Johnson aims to part ways with its orthopedics unit, which will take with ...